BRIACELL THERAPEUTICS CORP. Investment Income, Interest
BRIACELL THERAPEUTICS CORP. (BCTX) reported Investment Income, Interest of $219.22 thousand for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-06-09
- BRIACELL THERAPEUTICS CORP. investment income, interest for the quarter ending 2026-04-30 was $219.22K, a 723.15% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. investment income, interest for the quarter ending 2026-01-31 was $105.64K, a 125.57% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. investment income, interest for the quarter ending 2025-10-31 was $48.48K, a 271.51% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. investment income, interest for the quarter ending 2025-07-31 was $33.44K, a 1672100.00% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. investment income, interest for fiscal 2025 was $119.96K, a 58.35% decline from fiscal 2024.
- BRIACELL THERAPEUTICS CORP. investment income, interest for fiscal 2024 was $288.02K, a 67.68% decline from fiscal 2023.
- BRIACELL THERAPEUTICS CORP. investment income, interest for fiscal 2023 was $891.21K, a 551.80% increase from fiscal 2022.
- BRIACELL THERAPEUTICS CORP. investment income, interest for fiscal 2022 was $136.73K, a 4242.05% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-04-30 | $219.22K 10-Q · filed 2026-06-09 | $324.86K derived: sum of 2 quarters · filed 2026-06-09 | $462.83K 10-Q · filed 2026-06-09 | $406.78K derived: sum of 4 quarters · filed 2026-06-09 |
| 2026-01-31 | $105.64K 10-Q · filed 2026-03-10 | $243.61K 10-Q · filed 2026-03-10 | $187.56K derived: sum of 3 quarters · filed 2026-03-10 | $214.20K derived: sum of 4 quarters · filed 2026-06-09 |
| 2025-10-31 | $48.48K 10-Q · filed 2025-12-11 | $81.93K derived: sum of 2 quarters · filed 2025-12-11 | $108.56K derived: sum of 3 quarters · filed 2026-06-09 | $155.39K derived: sum of 4 quarters · filed 2026-06-09 |
| 2025-07-31 | $33.44K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | $60.08K derived: sum of 2 quarters · filed 2026-06-09 | $106.91K derived: sum of 3 quarters · filed 2026-06-09 | $119.96K 10-K · filed 2025-10-16 |
| 2025-04-30 | $26.63K 10-Q · filed 2026-06-09 | $73.46K derived: sum of 2 quarters · filed 2026-06-09 | $86.51K 10-Q · filed 2026-06-09 | $86.52K derived: sum of 4 quarters · filed 2026-06-09 |
| 2025-01-31 | $46.83K 10-Q · filed 2026-03-10 | $59.88K 10-Q · filed 2026-03-10 | $59.88K derived: sum of 3 quarters · filed 2026-03-10 | $75.49K derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-10-31 | $13.05K 10-Q · filed 2025-12-11 | $13.05K derived: sum of 2 quarters · filed 2025-12-11 | $28.66K derived: sum of 3 quarters · filed 2025-12-11 | $110.25K derived: sum of 4 quarters · filed 2025-12-11 |
| 2024-07-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | $15.61K derived: sum of 2 quarters · filed 2025-10-16 | $97.20K derived: sum of 3 quarters · filed 2025-10-16 | $288.02K 10-K · filed 2025-10-16 |
| 2024-04-30 | $15.61K 10-Q · filed 2025-06-16 | $97.20K derived: sum of 2 quarters · filed 2025-06-16 | $288.02K 10-Q · filed 2025-06-16 | $496.79K derived: sum of 4 quarters · filed 2025-06-16 |
| 2024-01-31 | $81.59K 10-Q · filed 2025-03-12 | $272.41K 10-Q · filed 2025-03-12 | $481.19K derived: sum of 3 quarters · filed 2025-03-12 | $734.67K derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-10-31 | $190.81K 10-Q · filed 2024-12-16 | $399.59K derived: sum of 2 quarters · filed 2024-12-16 | $653.08K derived: sum of 3 quarters · filed 2024-12-16 | $893.67K derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $208.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-29 | $462.26K derived: sum of 2 quarters · filed 2024-10-29 | $702.86K derived: sum of 3 quarters · filed 2024-10-29 | $891.21K 10-K · filed 2024-10-29 |
| 2023-04-30 | $253.49K 10-Q · filed 2024-06-14 | $494.08K derived: sum of 2 quarters · filed 2024-06-14 | $682.44K 10-Q · filed 2024-06-14 | $764.79K derived: sum of 4 quarters · filed 2024-06-14 |
| 2023-01-31 | $240.59K 10-Q · filed 2024-03-18 | $428.95K 10-Q · filed 2024-03-18 | $511.31K derived: sum of 3 quarters · filed 2024-03-18 | $547.29K derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | $188.35K 10-Q · filed 2023-12-14 | $270.71K derived: sum of 2 quarters · filed 2023-12-14 | $306.70K derived: sum of 3 quarters · filed 2023-12-14 | $318.78K derived: sum of 4 quarters · filed 2023-12-14 |
| 2022-07-31 | $82.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-25 | $118.34K derived: sum of 2 quarters · filed 2023-10-25 | $130.43K derived: sum of 3 quarters · filed 2023-10-25 | $136.73K 10-K · filed 2023-10-25 |
| 2022-04-30 | $35.99K 10-Q · filed 2023-06-14 | $48.07K derived: sum of 2 quarters · filed 2023-06-14 | $54.37K 10-Q · filed 2023-06-14 | |
| 2022-01-31 | $12.08K 10-Q · filed 2023-03-16 | $18.39K 10-Q · filed 2023-03-16 | ||
| 2021-10-31 | $6.30K 10-Q · filed 2022-12-14 | |||
| 2021-07-31 | $3.15K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |